Literature DB >> 31749350

Inflammatory Microenvironment of Acute Myocardial Infarction Prevents Regeneration of Heart with Stem Cells Therapy.

Saeed Khodayari1,2,3, Hamid Khodayari1,2,3, Ali Zahedi Amiri4,5, Maryam Eslami6, Dariush Farhud7,8, Jürgen Hescheler2,9, Karim Nayernia10,3,7.   

Abstract

Over the past years, the benefits of stem cell therapy approach for treatment of the cardiovascular diseases have been shown through the rebuilding of new cardiomyocytes and blood vessels. while a successful regeneration of the myocardium has been proven on the animal models of acute myocardial injuries resulted from the stem cells transplantation, no significant long-term regenerative with autologous stem cell therapy in patients with acute myocardial infarction have been reported based on recent meta-analyses. It seems that the inflammatory microenvironment of acute myocardial infarction has an inhibitory effect on the stem cells potential for regenerating the injured myocardium. Secretion of critical cytokines with pro-inflammatory properties including tumor necrosis factor-α, interleukin-1β, and interleukin-6 as well as induction of hypoxic condition and finally formation of cytotoxic elements cause the cellular death and hinder the stem cells proliferation and differentiation. Based on the evidence, application of some approaches like co-delivery of mesenchymal stem cells with the other useful cells, using the stem cells derived productions, administration of preconditioned and modified cells, and also using the anti-inflammatory agents besides the cell therapy are hypothesized as the primary developed safe and practical approaches for decreasing destructive effects of the inflammation on the implanted stem/progenitor cells. In this review, we critically discuss the quiddity of the inflammatory microenvironment and its promoted mechanisms as the main elements to hinder the efficacy of stem cell therapy in the cases of acute myocardial infarction. Also, we finally propose some applied solutions to the problem of cardiac regeneration with stem cells therapy. © Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Entities:  

Keywords:  Acute myocardial infarction; Inflammatory microenvironment; Stem cell therapy

Mesh:

Substances:

Year:  2019        PMID: 31749350     DOI: 10.33594/000000180

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  24 in total

Review 1.  Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects.

Authors:  Mia Karam; Duaa Fahs; Batoul Maatouk; Brouna Safi; Ayad A Jaffa; Rami Mhanna
Journal:  Mater Today Bio       Date:  2022-04-04

2.  Adiponectin improves the therapeutic efficacy of mesenchymal stem cells by enhancing their engraftment and survival in the peri-infarct myocardium through the AMPK pathway.

Authors:  Xia-Qiu Tian; Xiao-Song Qian; Hong Wang; Yue-Jin Yang
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Mesenchymal Stem Cell-Derived Extracellular Vesicle-Shuttled microRNA-302d-3p Represses Inflammation and Cardiac Remodeling Following Acute Myocardial Infarction.

Authors:  Yuanyuan Liu; Rongchun Guan; Jizhou Yan; Yueping Zhu; Shiming Sun; Yan Qu
Journal:  J Cardiovasc Transl Res       Date:  2022-02-22       Impact factor: 4.132

4.  Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method.

Authors:  Luiza L Bagno; Alessandro G Salerno; Wayne Balkan; Joshua M Hare
Journal:  Expert Opin Biol Ther       Date:  2021-12-27       Impact factor: 4.388

5.  Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular function: a meta-analysis of clinical trials.

Authors:  Alireza Hosseinpour; Fatemeh Kheshti; Asma Kazemi; Armin Attar
Journal:  Stem Cell Res Ther       Date:  2022-05-16       Impact factor: 8.079

Review 6.  Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.

Authors:  Hamid Khodayari; Saeed Khodayari; Elmira Ebrahimi; Farimah Hadjilooei; Miko Vesovic; Habibollah Mahmoodzadeh; Tomo Saric; Wilfried Stücker; Stefaan Van Gool; Jürgen Hescheler; Karim Nayernia
Journal:  Cancer Immunol Immunother       Date:  2021-07-04       Impact factor: 6.968

7.  Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction.

Authors:  HuiYa Li; DanQing Hu; Guilin Chen; DeDong Zheng; ShuMei Li; YunLing Lin; HuaShan Hong; Yukun Luo; YiLang Ke; Yu Huang; LingZhen Wu; TingXiang Lan; WenYing Wang; Jun Fang
Journal:  Cell Death Dis       Date:  2021-05-18       Impact factor: 8.469

Review 8.  The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease.

Authors:  Chuanbin Liu; Dong Han; Ping Liang; Yang Li; Feng Cao
Journal:  Front Cell Dev Biol       Date:  2021-04-22

9.  Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods.

Authors:  Siyu Guo; Jiarui Wu; Wei Zhou; Xinkui Liu; Yingying Liu; Jingyuan Zhang; Shanshan Jia; Jialin Li; Haojia Wang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

10.  17-estradiol nanoparticles influence inflammatory response of myocardial infarction possibly through downregulation of miR-302b.

Authors:  Hao Ma; Dong Xu; Fei Liu; Qing Yao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.